C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2004
12/28/2004	US6835371 Diagnostic and therapeutic piperazine and piperidine compounds and process
12/23/2004	WO2004111108A1 Diamine having quinoxaline unit, polyimide precursor, polyimide and use thereof
12/23/2004	WO2004111039A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	WO2004111034A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110983A2 New benzamides as pparϒ modulators
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004080958A3 Process to tetrahydrotriazolopyrazines and intermediates
12/23/2004	WO2004073629A3 Hetero substitued sodium channel blockers
12/23/2004	WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/23/2004	CA2528231A1 New benzamides as ppar.gamma. modulators
12/23/2004	CA2527037A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2527035A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487795A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	EP1044961B1 Iron alkali salt of s,s-ethylenediamine-n,n'-disuccinic acid and process for producing the same
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/21/2004	US6833369 Treatment of ocular neovascular diseases, neovascular glaucoma, diabetic retinopathy,
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/15/2004	EP1486489A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	WO2003104206A3 Herbicidally active heterocyclylalkynes
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	CA2527632A1 Benzamide nitrile derivatives
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482919A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
12/08/2004	CN1552693A Benzoylcyclohexanone amine compounds with herbicidal activity
12/08/2004	CN1552689A Aroxyphenoxy carboxylic acid ester compounds with herbicidal activity
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828316 Antiallergens
12/02/2004	WO2004103309A2 Immunosuppressant compounds and compositions
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242684 Method and compositions for inhibiting cell proliferative disorders
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
12/02/2004	US20040242584 Muscarinic agonists
12/02/2004	US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004	US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
12/02/2004	US20040241563 Phenothiazine, phenoxazine, or phenazine derivatives; organophotoreceptor comprising electricoconductive substrate and photoconductive element; mechanical, electrostatic, and solubility properties; used with toners for quality images
12/02/2004	DE10321565A1 Production of polyalkyl-dihydropyrazine, used as intermediates for pyrazine derivative aroma materials, by reacting diamine with diketone in the absence of alkaline stabilizers
12/01/2004	EP1482376A1 Charge transport materials having heteroaromatic hydrazone groups
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551771A Method and composition for treatment of cancer
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825351 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (r)- and (s)-forms
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/25/2004	US20040236107 Intermediate compounds for the preparation of mirtazapine and the production methods thereof
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1185536B1 Hemisynthetic method and intermediates thereof
11/23/2004	US6822062 Supported group 8-10 transition metal olefin polymerization catalysts

1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 187